Gladstone Land Corporation 6.00% Series B Cumulative Redeemable Preferred Stock (LANDO)
Fast GrowerFairStock Score: 74/100 — STEADY
Key Financials
| Current Price | $20.88 |
| Market Cap | — |
| P/E Ratio | -71.98 |
| ROE | -0.85% |
| Dividend Yield | 7.25% |
| Sector | Real Estate |
Strengths
- Strong Piotroski F-Score of 7/9 indicating robust financial health across profitability, leverage, and efficiency metrics
- Revenue growth of 96.5% demonstrates strong top-line momentum
- Attractive 7.2% dividend yield providing steady income returns
- FairStock composite score of 74/100 places it in the top tier across value, quality, and momentum factors
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
AI Analysis
Gladstone Land Corporation 6.00% Series B Cumulative Redeemable Preferred Stock is a micro-cap real estate company. Revenue stands at $88 million, though the company is currently unprofitable. From a quality standpoint, Gladstone shows solid Piotroski F-Score of 7/9 and negative ROE indicating losses. Growth dynamics show revenue growing at 96.5% and profit growth of 680.0%. The 7.2% dividend yield adds an income component for patient holders. Our composite FairStock Score of 74/100 reflects above-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Gladstone's 97% revenue growth trajectory could accelerate as it captures additional market share in the real estate sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer